Severe gastrointestinal conditions : Patients with gastrointestinal conditions such as gastroparesis or inflammatory bowel disease must exercise caution
The least-squares mean percentage change in body weight at 24 weeks in the retatrutide groups was 7.2% in the 1-mg group, 12.9% in the combined 4-mg group, 17.3% in the combined 8-mg group, and 17.5% in the 12-mg group, as compared with 1.6% in the placebo group
Here is what the clinical data shows about early side effects and how to manage them
And then when we began working with Ten Thousand Villages, I knew we shared the same values and would make a good team
2025, doi: 10.14309/ajg.0000000000003760
Quotes without any clinical assessment are not protocols: A price for retatrutide injections with no preceding metabolic workup, no cardiovascular evaluation, and no physician prescription attached means the safety framework simply isnt there regardless of what the quote claims to include